US charges Cassava Sciences, two former executives for misleading claims about Alzheimer’s clinical trial
The U.S. Securities and Exchange Commission said on Thursday that it charged Cassava Sciences and two of the company's former executives for misleading claims about the results of Alzheimer’s clinical trials.
SEC Announces $40 Mln Settlement With Cassava Sciences Over Misleading Alzheimer's Trial Statements
The U.S. Securities and Exchange Commission announced Cassava Sciences Inc. (SAVA), its founder and former CEO, Remi Barbier, and its
Cassava Sciences settles SEC charges of ‘misleading’ Alzheimer’s trial claims
Shares of Cassava Sciences Inc. dropped more than 10% in the extended session Thursday after announcing a settlement with U.S. securities regulators, who had charged the pharma company and two former executives for “misleading claims” about an Alzheimer’s clinical trial.
Cassava Sciences shares fall after SEC charges for misleading Alzheimer's drug trial claims
Shares of Cassava Sciences fell 10% in post-market trading on Thursday after the U.S. Securities and Exchange Commission charged the biopharmaceutical company and two former executives for misleading claims about the results of Alzheimer's clinical trials.
Cassava settles SEC charges related to Alzheimer’s candidate for $40M
Cassava Sciences settles SEC charges for $40M over misleading Alzheimer's drug trial results, ex-CEO and SVP also face negligence charges.
Cassava Sciences and former execs, facing SEC charges for misleading claims, agree to fines
Cassava and former executives were charged Thursday by the SEC with making misleading claims in 2020 about trials for the Alzheimer's drug simufilam, and agreed to pay fines.
Alzheimer's treatment that uses Benfotiamine will be tested in large clinical trial
Researcher Gary Gibson talks at Burke in White Plains about a trial on a new treatment for Alzheimer’s that uses Benfotiamine ...
BLACK ENTERPRISE Empowers Black Men: Prostate Cancer In The Black Community And The Importance Of Clinical Trials
Prostate cancer disproportionately affects Black men, leading to higher mortality rates and worse health outcomes compared to ...
MyChesCo on MSN15h
YPrime Releases Report on Enhancing Clinical Trial Technology
YPrime has unveiled a pivotal research report titled “A Sponsor’s Guide to Leveraging Site Insights for Smarter Technology ...
New AI model enhances clinical trial approval predictions by quantifying uncertainty
Researchers from Stanford University and Rensselaer Polytechnic Institute have developed an advanced AI model that improves ...
EXCLUSIVE: Vivani Medical Advances Its Obesity Treatment Implant With New Clinical Trial in Australia
Vivani Medical receives approval for the first human trial of its GLP-1 obesity implant in Australia. The LIBERATE-1 trial ...
Pasithea Announces Positive Initial Data From Phase 1 Trial Of PAS-004 In Advanced Cancer; Stock Up
Pasithea Therapeutics Corp. (KTTA) reported positive initial results from its Phase 1 clinical trial of PAS-004, a new ...
Medical Xpress on MSN3d
Clinical trial supports adding ruxolitinib to tyrosine kinase inhibitors for chronic myeloid leukemia
Researchers leading the SWOG S1712 clinical trial have found that adding ruxolitinib to standard tyrosine kinase ...
MedPage Today16h
Placebos Linked to Potential Harms in IBD Clinical Trials
The findings highlight the potential harms associated with receiving placebo in placebo-controlled IBD trials, "which might ...
FierceBiotech2d
Clinical trial site network Headlands Research opens new location in El Paso, Texas
Headlands Research, a clinical trial site network with locations across the United States and Canada, is launching its newest ...
The Lancet13d
The literacy barrier in clinical trial consents: a retrospective analysis
The average readability of informed consent forms of federally funded clinical trials exceeds the reading comprehension ...
Chronic Low Back Pain (CLBP) Global Clinical Trials Review 2024:Country (G7 & E7), Trial Status, Trial Phase, Sponsor Type and End Point Status
The "Chronic Low Back Pain (CLBP) - Global Clinical Trials Review, 2024" clinical trials has been added to ResearchAndMarkets.com's offering.The clinical trial report, "Chronic Low Back Pain (CLBP) - ...